Skip to main content
. 2019 Feb 24;10(1):24–33. doi: 10.14740/cr813

Figure 2.

Figure 2

Mean reduction (mm Hg) in sitting systolic blood pressure (msSBP) in hypertensive patients treated with sacubitril/valsartan compared to ARB-treated controls. (a) In the control group olmesartan was used as comparator drug. (b) In the control group valsartan was used as comparator drug. pts: patients; st.dev: standard deviation; ctrl: controls; ARBs: angiotensin receptor blockers; CI: confidence interval.